Literature DB >> 20045565

Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13.

Rajiv Raman1, Padmaja Kumari Rani, Vaitheeswaran Kulothungan, Sudhir Reddi Rachepalle, Govindasamy Kumaramanickavel, Tarun Sharma.   

Abstract

PURPOSE: To estimate the prevalence of diabetic macular edema, both clinically significant macular edema (CSME) and nonclinically significant macular edema (non-CSME), and report the associations of dyslipidemia on them.
DESIGN: A population-based cross-sectional study in India. PARTICIPANTS: After all exclusions, 1414 subjects with diabetes underwent an examination.
METHODS: The CSME was defined according to the Early Treatment Diabetic Retinopathy Study (ETDRS) guidelines; stereo digital fundus pairs were studied. The dyslipidemia cases were classified according to the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III). MAIN OUTCOME MEASURES: Prevalence of CSME and non-CSME and association of serum lipids with them.
RESULTS: The prevalence was 31.76% (95% confidence interval [CI], 26.04-37.47) for overall diabetic macular edema, 25.49% (95% Ci, 20.14-30.84) for non-CSME, and 6.27% (95% Ci, 3.29-9.24) for CSME. Univariate analysis identified macroalbuminuria and microalbuminuria, poor glycemic control, high total serum cholesterol, high serum low-density lipoprotein (LDL) cholesterol, and high serum non-high-density lipoprotein (HDL) cholesterol related to non-CSME and CSME (trend chi-square test, P<0.05). Logistic regression analysis (after adjusting variables such as age, gender, body mass index, duration, smoking, hypertension, glycosylated hemoglobin, macroalbuminuria and microalbuminuria, and insulin use) revealed high serum LDL cholesterol (odds ratio [OR], 2.72], high serum non-HDL cholesterol (OR, 1.99), and high cholesterol ratio (OR, 3.08) related to non-CSME, and poor glycemic control (OR, 8.06), microalbuminuria (OR, 14.23), and high serum total cholesterol (OR, 9.09) related to CSME.
CONCLUSIONS: One third of the subjects had diabetic macular edema, and 6% of them showed evidence of CSME necessitating laser photocoagulation. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article. Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045565     DOI: 10.1016/j.ophtha.2009.09.005

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

Review 2.  Dyslipidemia and diabetic retinopathy.

Authors:  Yo-Chen Chang; Wen-Chuan Wu
Journal:  Rev Diabet Stud       Date:  2013-08-10

3.  Association of serum lipid levels with diabetic retinopathy.

Authors:  Ebru Nevin Cetin; Yunus Bulgu; Seyfullah Ozdemir; Senay Topsakal; Fulya Akın; Hulya Aybek; Cem Yıldırım
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 4.  Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.

Authors:  Alicia J Jenkins; Maria B Grant; Julia V Busik
Journal:  Diabetologia       Date:  2022-02-11       Impact factor: 10.460

5.  Correlation of morphological pattern of optical coherence tomography in diabetic macular edema with systemic risk factors in middle aged males.

Authors:  Sambuddha Ghosh; Preeti Bansal; Harsha Shejao; Raghuraj Hegde; Debesh Roy; Shyamapada Biswas
Journal:  Int Ophthalmol       Date:  2014-03-01       Impact factor: 2.031

6.  OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF MACULAR EDEMA AND HARD EXUDATES AND THEIR ASSOCIATION WITH LIPID SERUM LEVELS IN TYPE 2 DIABETES.

Authors:  Samaneh Davoudi; Evangelia Papavasileiou; Ramak Roohipoor; Heeyoon Cho; Shreyas Kudrimoti; Heather Hancock; Suzanne Hoadley; Christopher Andreoli; Deeba Husain; Maurice James; Alan Penman; Ching J Chen; Lucia Sobrin
Journal:  Retina       Date:  2016-09       Impact factor: 4.256

7.  Long-term effectiveness of vitrectomy in diabetic cystoid macular edema.

Authors:  Javier Navarrete-Sanchis; Julian Zarco-Bosquets; Juan Miguel Tomas-Torrent; Teresa Diago; Leticia Ortega-Evangelio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-24       Impact factor: 3.117

Review 8.  Current epidemiology of diabetic retinopathy and diabetic macular edema.

Authors:  Jie Ding; Tien Yin Wong
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

9.  Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids.

Authors:  Muhammad Bayu Sasongko; Tien Y Wong; Thanh T Nguyen; Ryo Kawasaki; Alicia Jenkins; Jonathan Shaw; Jie Jin Wang
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

10.  Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus.

Authors:  Yu Wang; Zhong Lin; Gang Zhai; Xiao Xia Ding; Liang Wen; Dong Li; Bo Zou; Ke Mi Feng; Yuan Bo Liang; Cong Xie
Journal:  Ophthalmic Res       Date:  2020-04-30       Impact factor: 3.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.